755 Pill - orange & white capsule/oblong, 21mm

Pill with imprint 755 is Orange & White, Capsule/Oblong and has been identified as Temozolomide 180 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.

Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 755

Temozolomide

Imprint: 755
Strength: 180 mg
Color: Orange & White
Size: 21.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Alkylating agents
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Zydus Pharmaceuticals (USA) Inc.
Manufacturer: Cadila Healthcare Limited
National Drug Code (NDC): 68382-0755
Inactive Ingredients: alcohol, ammonia, lactose anhydrous, butyl alcohol, ferric oxide red, ferric oxide yellow, ferrosoferric oxide, gelatin, isopropyl alcohol, potassium hydroxide, propylene glycol, shellac, silicon dioxide, sodium lauryl sulfate, sodium starch glycolate type B potato, stearic acid, tartaric acid, titanium dioxide, water
Note: Inactive ingredients may vary.